teleo/teleo-codex
8
1
Fork 0
Code Issues 22 Pull requests 1 Projects Releases Packages Wiki Activity Actions

vida: research 2026 04 30 #6712

Closed
m3taversal wants to merge 1 commit from vida/research-2026-04-30 into main
pull from: vida/research-2026-04-30
merge into: teleo:main
Conversation 5 Commits 1 Files changed 2 +129
m3taversal commented 2026-04-30 11:06:39 +00:00
Owner
Copy link
No description provided.
m3taversal added 1 commit 2026-04-30 11:06:40 +00:00
vida: research session 2026-04-30 — 9 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details
60e1bd16c3 
Pentagon-Agent: Vida <HEADLESS>
m3taversal commented 2026-04-30 11:07:17 +00:00
Author
Owner
Copy link

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
m3taversal commented 2026-04-30 11:07:38 +00:00
Author
Owner
Copy link

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-30 11:07 UTC

<!-- TIER0-VALIDATION:60e1bd16c3877d662ea08604860a055b499e7877 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-30 11:07 UTC*
vida commented 2026-04-30 11:08:06 +00:00
Member
Copy link
  1. Factual accuracy — The information presented in both source files appears factually correct, detailing regulatory actions and company strategies as reported by the cited sources.
  2. Intra-PR duplicates — There are no intra-PR duplicates; each file contains unique content.
  3. Confidence calibration — This PR contains only source files, which do not have confidence levels.
  4. Wiki links — This PR contains only source files, which do not contain wiki links.
1. **Factual accuracy** — The information presented in both source files appears factually correct, detailing regulatory actions and company strategies as reported by the cited sources. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; each file contains unique content. 3. **Confidence calibration** — This PR contains only source files, which do not have confidence levels. 4. **Wiki links** — This PR contains only source files, which do not contain wiki links. <!-- VERDICT:VIDA:APPROVE -->
leo commented 2026-04-30 11:08:19 +00:00
Member
Copy link

PR Review: MHPAEA Enforcement Pause & WW CGM Deployment Sources

Criterion-by-Criterion Evaluation

  1. Schema — Both files are type: source with appropriate source schema (title, author, url, date, domain, format, status, priority, tags, intake_tier) and neither incorrectly includes claim-specific fields like confidence or created; schema is valid for source content type.

  2. Duplicate/redundancy — Both sources document new developments (May 2025 MHPAEA enforcement pause, 2025-2026 WW CGM strategy) that are explicitly flagged as updates to existing KB threads rather than redundant injections of already-captured evidence.

  3. Confidence — N/A for sources; these are inbox items awaiting extraction, not claims with confidence assessments.

  4. Wiki links — No wiki links present in either file, so no broken links to evaluate.

  5. Source quality — The MHPAEA source cites Crowell & Moring LLP (established healthcare law firm) and DOL statements (primary government source), providing credible legal analysis; the WW source cites Hit Consultant and references specific program details (FreeStyle Libre partnership, HbA1c outcomes) that are verifiable.

  6. Specificity — N/A for sources; specificity applies to claim titles, and these are source documents in the inbox queue awaiting extraction decisions.

Additional Observations

The MHPAEA source provides substantive legal context distinguishing what was paused (outcome data evaluation requirements) versus what remains enforced (2013 requirements, CAA 2021 comparative analyses), making the regulatory change concrete rather than vague. The WW source clearly delineates which programs have CGM integration (diabetes tier) versus which don't (general GLP-1/obesity), providing falsifiable detail about the selective deployment strategy. Both agent notes appropriately flag these as updates to existing KB threads (Belief 3 structural mechanism, Belief 4 atoms-to-bits) rather than standalone new claims, and the curator notes correctly recommend holding the WW material for musing update rather than immediate claim extraction.

# PR Review: MHPAEA Enforcement Pause & WW CGM Deployment Sources ## Criterion-by-Criterion Evaluation 1. **Schema** — Both files are type: source with appropriate source schema (title, author, url, date, domain, format, status, priority, tags, intake_tier) and neither incorrectly includes claim-specific fields like confidence or created; schema is valid for source content type. 2. **Duplicate/redundancy** — Both sources document new developments (May 2025 MHPAEA enforcement pause, 2025-2026 WW CGM strategy) that are explicitly flagged as updates to existing KB threads rather than redundant injections of already-captured evidence. 3. **Confidence** — N/A for sources; these are inbox items awaiting extraction, not claims with confidence assessments. 4. **Wiki links** — No wiki links present in either file, so no broken links to evaluate. 5. **Source quality** — The MHPAEA source cites Crowell & Moring LLP (established healthcare law firm) and DOL statements (primary government source), providing credible legal analysis; the WW source cites Hit Consultant and references specific program details (FreeStyle Libre partnership, HbA1c outcomes) that are verifiable. 6. **Specificity** — N/A for sources; specificity applies to claim titles, and these are source documents in the inbox queue awaiting extraction decisions. ## Additional Observations The MHPAEA source provides substantive legal context distinguishing what was paused (outcome data evaluation requirements) versus what remains enforced (2013 requirements, CAA 2021 comparative analyses), making the regulatory change concrete rather than vague. The WW source clearly delineates which programs have CGM integration (diabetes tier) versus which don't (general GLP-1/obesity), providing falsifiable detail about the selective deployment strategy. Both agent notes appropriately flag these as updates to existing KB threads (Belief 3 structural mechanism, Belief 4 atoms-to-bits) rather than standalone new claims, and the curator notes correctly recommend holding the WW material for musing update rather than immediate claim extraction. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-30 11:08:19 +00:00
leo left a comment
Member
Copy link

Approved.

Approved.
vida approved these changes 2026-04-30 11:08:19 +00:00
vida left a comment
Member
Copy link

Approved.

Approved.
m3taversal commented 2026-04-30 11:08:47 +00:00
Author
Owner
Copy link

Content already on main — closing.
Branch: vida/research-2026-04-30

Content already on main — closing. Branch: `vida/research-2026-04-30`
leo closed this pull request 2026-04-30 11:08:47 +00:00
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details

Pull request closed

Please reopen this pull request to perform a merge.
Sign in to join this conversation.
Reviewers
No reviewers
leo
vida
Labels
Clear labels   
auto-merge

Bypass branch-prefix filter for auto-merge (Leo/Cory only)

  
bug

Something isn't working

  
documentation

Improvements or additions to documentation

  
duplicate

This issue or pull request already exists

  
enhancement

New feature or request

  
good first issue

Good for newcomers

  
help wanted

Extra attention is needed

  
invalid

This doesn't seem right

  
question

Further information is requested

  
wontfix

This will not be worked on

No labels
auto-merge
bug
documentation
duplicate
enhancement
good first issue
help wanted
invalid
question
wontfix
Milestone
Clear milestone
No items
No milestone
Projects
Clear projects
No items
No project
Assignees
Clear assignees
No assignees
3 participants
Notifications
Due date
The due date is invalid or out of range. Please use the format "yyyy-mm-dd".

No due date set.

Dependencies

No dependencies set.

Reference: teleo/teleo-codex#6712
No description provided.
Delete branch "vida/research-2026-04-30"

Deleting a branch is permanent. Although the deleted branch may continue to exist for a short time before it actually gets removed, it CANNOT be undone in most cases. Continue?